iBio Insider Ownership

NASDAQ IBIO
$0.82 +0.06 (+8.01%)
At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

309.97K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.293%
■0% pp QoQ
Shares Held by Insiders
304.86K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
104.06Mn
104,060,000 shares
Direct Holdings
121.04K
Indirect: 183.82K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the past year, IBIO insiders bought $98,106 of stock (51.1K shares) on the open market and sold none.

Form 4 Holdings

Insiders Holding IBIO

Insiders 8
Shares held 309.97K
Of outstanding 0.298%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Antonio Bernardino Guimaraes Parada Director 0 183,823 183,823 59.3% 13 Jan, 2025
2 Felipe Duran Chief Financial Officer 35,974 0 35,974 11.6% 23 Mar, 2026
3 Martin Brenner Chief Scientific Officer 30,652 0 30,652 9.9% 23 Mar, 2026
4 Marc Banjak Chief Legal Officer 25,000 0 25,000 8.1% 27 Mar, 2026
5 David Arkowitz Director 18,382 0 18,382 5.9% 13 Jan, 2025
6 Gary Sender Director 9,191 0 9,191 3.0% 13 Jan, 2025
7 Robert Matthew Lutz Officer 5,108 0 5,108 1.6% 15 Nov, 2022
8 William D Clark Director 1,838 0 1,838 0.6% 13 Jan, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

273 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
14 Oct, 2026 Gary Sender Director Acquired A 38,000 $0.00 $0 38,000 Direct
14 Oct, 2026 Antonio Bernardino Guimaraes Parada Director Acquired A 38,000 $0.00 $0 38,000 Direct
14 Oct, 2026 William D Clark Director Acquired A 38,000 $0.00 $0 38,000 Direct
14 Oct, 2026 Alexandra Kropotova Director Acquired A 38,000 $0.00 $0 38,000 Direct
14 Oct, 2026 David Arkowitz Director Acquired A 38,000 $0.00 $0 38,000 Direct
14 Oct, 2026 Elizabeth Stoner Director Acquired A 38,000 $0.00 $0 38,000 Direct
31 Jul, 2026 Molly Carr Chief Medical Officer Acquired A 430,000 $0.00 $0 430,000 Direct
18 May, 2026 Elizabeth Stoner Director Acquired A 60,000 $0.00 $0 60,000 Direct
26 Mar, 2026 Marc Banjak Chief Legal Officer Acquired P 12,500 $1.64 $20.53K 23,566 Direct
26 Mar, 2026 Marc Banjak Chief Legal Officer Acquired P 1,434 $1.76 $2.52K 25,000 Direct
19 Mar, 2026 Felipe Duran Chief Financial Officer Acquired P 24,835 $2.02 $50.13K 35,974 Direct
19 Mar, 2026 Martin Brenner Director, Officer Acquired P 12,336 $2.02 $24.92K 30,652 Direct
28 Jan, 2026 Felipe Duran Chief Financial Officer Acquired A 179,000 $0.00 $0 179,000 Direct
28 Jan, 2026 Martin Brenner Director, Officer Acquired A 479,000 $0.00 $0 479,000 Direct
28 Jan, 2026 Marc Banjak Chief Legal Officer Acquired A 146,000 $0.00 $0 146,000 Direct
20 Nov, 2025 Antonio Bernardino Guimaraes Parada Director Acquired A 13,500 $0.00 $0 13,500 Direct
20 Nov, 2025 Alexandra Kropotova Director Acquired A 13,500 $0.00 $0 13,500 Direct
20 Nov, 2025 Evert B. Schimmelpennink Director Acquired A 13,500 $0.00 $0 13,500 Direct
20 Nov, 2025 Gary Sender Director Acquired A 13,500 $0.00 $0 13,500 Direct
20 Nov, 2025 David Arkowitz Director Acquired A 13,500 $0.00 $0 13,500 Direct